IDSA Action Center
Welcome to the IDSA Action Center, bringing you the latest updates from IDWeek. This collection features state-of-the-art developments in infectious diseases and healthcare epidemiology to help bridge the gap between clinical practice and research and to help promote collaboration between clinicians, researchers, and pharmacists.
1-15 of 34

Advancing STI Care: What’s New and Where Gaps Remain
Clinician's RoundtableAdvancing STI Care: What’s New and Where Gaps Remain

AI in Infectious Disease Care: Promise and Practical Limits
Clinician's RoundtableAI in Infectious Disease Care: Promise and Practical Limits

When to Consider Switching ART in Patients with Virologically Suppressed HIV
Clinician's RoundtableWhen to Consider Switching ART in Patients with Virologically Suppressed HIV

Real-World Evidence on Long-Acting CAB/RPV in Patients with Viremia
Clinician's RoundtableReal-World Evidence on Long-Acting CAB/RPV in Patients with Viremia

Assessing HIV Treatment and PrEP Adherence with Hair and Urine Samples
Clinician's RoundtableAssessing HIV Treatment and PrEP Adherence with Hair and Urine Samples

IDWeek 2026 Highlights: Perspectives from the Chair and Vice-Chair
Clinician's RoundtableIDWeek 2026 Highlights: Perspectives from the Chair and Vice-Chair
- advertisement

Identifying Mpox Hospitalization Risks in Patients with HIV During the 2022 Outbreak
Clinician's RoundtableIdentifying Mpox Hospitalization Risks in Patients with HIV During the 2022 Outbreak

Identifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey
Clinician's RoundtableIdentifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey

Rising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal
Clinician's RoundtableRising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal

Improved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
Clinician's RoundtableImproved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing

First-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine
Clinician's RoundtableFirst-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine

DOR/ISL Two-Drug Regimen for HIV-1 Is Non-Inferior to BIC/FTC/TAF
Clinician's RoundtableDOR/ISL Two-Drug Regimen for HIV-1 Is Non-Inferior to BIC/FTC/TAF
- advertisement

Hepatitis B Reactivation in HIV: A Recap of Data from IDWeek 2023
Clinician's RoundtableHepatitis B Reactivation in HIV: A Recap of Data from IDWeek 2023

The Latest on Antifungal Vaccines: Updates from IDWeek 2023
Clinician's RoundtableThe Latest on Antifungal Vaccines: Updates from IDWeek 2023

What’s New in Infectious Diseases? Takeaways from IDWeek 2023
Clinician's RoundtableWhat’s New in Infectious Diseases? Takeaways from IDWeek 2023






































